Mast cells are essential intermediaries in regulatory T-cell tolerance

Nature

Volumn 442, Issue 7106, 2006, Pages 997-1002

  Lu, Li Fan ^a   Lind, Evan F ^a   Gondek, David C ^a   Bennett, Kathy A ^a   Gleeson, Michael W ^a   Pino Lagos, Karina ^a   Scott, Zachary A ^a   Coyle, Anthony J ^b   Reed, Jennifer L ^b   Van Snick, Jacques ^c   Strom, Terry B ^d   Zheng, Xin Xiao ^d   Noelle, Randolph J ^a  

^a NORRIS COTTON CANCER CENTER   (United States)

^b Department of Autoimmunity and Inflammation MedImmune ^*  (United States)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIES; ANTIGEN-ANTIBODY REACTIONS; CELLS; GENES; GRAFT VS. HOST REACTIONS; GROWTH KINETICS; HISTOLOGY; TISSUE;

ALLOGRAFTS; IMMUNOHISTOCHEMICAL ANALYSIS; INTERLEUKIN (IL); MAST CELLS;

IMMUNOLOGY;

INTERLEUKIN 9;

ABNORMALITY; CELL ORGANELLE; IMMUNOASSAY; PROTEIN; RODENT;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

EID: 33748320914     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05010     Document Type: Article

References (30)

1. + regulatory T cells in immunological tolerance to self and non-self. Nature Immunol. 6, 345-352 (2005).
2. Quezada, S. A. et al. Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: the interplay of clonal anergy and immune regulation. J. Immunol. 175, 771-779 (2005).
3. + immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J. Exp. Med. 193, 1311-1318 (2001).
4. Galli, S. J., Nakae, S. & Tsai, M. Mast cells in the development of adaptive immune responses. Nature Immunol. 6, 135-142 (2005).
5. Galli, S. J. et al. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23, 749-786 (2005).
6. Benoist, C. & Mathis, D. Mast cells in autoimmune disease. Nature 420, 875-878 (2002).
7. + T-cell subsets in determining transplantation rejection or tolerance. Immunol. Rev. 182, 164-179 (2001).
8. Graca, L., Cobbold, S. P. & Waldmann, H. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195, 1641-1646 (2002).
9. Hara, M. et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166, 3789-3796 (2001).
10. Corti, B. et al. Potential of real-time PCR assessment of granzyme B and perforin up-regulation for rejection monitoring in intestinal transplant recipients. Transplant. Proc. 37, 4467-4471 (2005).
11. Wang, H. W., Tedla, N., Lloyd, A. R., Wakefield, D. & McNeil, P. H. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J. Clin. Invest. 102, 1617-1626 (1998).
12. 57, and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit. Blood 94, 2658-2666 (1999).
13. sh mice: age-dependent abolishment of c-kit gene expression. Blood 83, 3509-3516 (1994).
14. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167, 835-848 (2005).
15. Van Snick, J. et al. Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J. Exp. Med. 169, 363-368 (1989).
16. Jarnicki, A. G. & Fallon, P. G. T helper type-2 cytokine responses: potential therapeutic targets. Curr. Opin. Pharmacol. 3, 449-455 (2003).
17. Zhou, Y., McLane, M. & Levitt, R. C. Th2 cytokines and asthma. Interleukin-9 as a therapeutic target for asthma. Respir. Res. 2, 80-84 (2001).
18. Townsend, J. M. et al. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T-cell development. Immunity 13, 573-583 (2000).
19. + regulatory T cells through GITR breaks immunological selftolerance. Nature Immunol. 3, 135-142 (2002).
20. Tone, M. et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl Acad. Sci. USA 100, 15059-15064 (2003).
21. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
22. + regulatory T cells contributes to skin transplant tolerance. Transplantation 76, 1375-1379 (2003).
23. Theoharides, T. C. & Conti, P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol. 25, 235-241 (2004).
24. Mesples, B., Fontaine, R. H., Lelievre, V., Launay, J. M. & Gressens, P. Neuronal TGF-β1 mediates IL-9/mast cell interaction and exacerbates excitotoxicity in newborn mice. Neurobiol. Dis. 18, 193-205 (2005).
25. Lee, G. K. & Mellor, A. L. Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division. Immunology 107, 452-460 (2002).
26. W-v mice to the development of 1,2-dimethylhydrazine-induced intestinal tumors. Lab. Invest. 85, 388-396 (2005).
27. Khan, W. I. et al. Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections. Infect. Immun. 71, 2430-2438 (2003).
28. Razin, E. Culture of bone marrow-derived mast cells: a model for studying oxidative metabolism of arachidonic acid and synthesis of other molecules derived from membrane phospholipids. Methods Enzymol. 187, 514-520 (1990).
29. εRI-mediated mast cell activation. Immunity 12, 525-535 (2000).
30. + regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783-1786 (2005).